NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Nalu Bio

Nalu Bio

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.nalubio.com/

Last Round

Series A

Feb 28, 2023

Total Funding Raised

$13.5M

Company Overview

Nalu Bio is a biotechnology company that has developed a drug discovery platform to accelerate the development of prescription and nonprescription health products targeting the endocannabinoid system (ECS).

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Sustainable Materials, Medical AI

Business Model

B2B2C

Customer Profile

Hardware Sales, Services & Consulting, Revenue Share

AI Layer

Application

Keywords

synthetic cannabinoidscannabinoid ingredientslab-grown cannabinoidsTHC-free CBDcannabinoid synthesisCPG ingredientsendocannabinoid systemECSdrug discovery platformpharmaceutical ingredientsAI drug discoverynew chemical entitiesNCEs

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nalu Bio Comparables

Compare Nalu Bio with similar companies based on industry and business-model similarity.

Nalu Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Creo
87%
Hyasynth Biologicals Inc.
82%
Lygos
76%

Nalu Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AFeb 28, 2023
SeedJan 7, 2021

Nalu Bio Investors

Notable investors and investment history

Nalu Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Nalu Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Nalu Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range15
Year Founded2019
Last FundingFeb 28, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.